OPKO Health

Company

Investment-firm

Last deal

$250M

Amount

Post-IPO Debt

Stage

17.07.2024

Date

4

all rounds

$656M

Total amount

General

About Company
OPKO Health is a global healthcare company offering diverse products and solutions.

Industry

Sector :

Subsector :

Also Known As

eXegenics

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Founded in 2007 by Dr. Phillip Frost, OPKO Health has grown into a global healthcare company with over 5,500 employees in nine countries. They provide first-in-class products like Rayaldee® and the 4Kscore® test, as well as diagnostics services through BioReference Laboratories and GeneDx. With a strong focus on research and development, OPKO Health aims to meet unmet patient needs and adapt to evolving healthcare demands. More information can be found at www.opko.com.
Contacts

Social url